Remedy Robotics Partners with Mission Thrombectomy
Remedy Robotics has entered a strategic partnership with Mission Thrombectomy, a leading clinician network dedicated to accelerating access to endovascular thrombectomy in stroke.
The partnership aims to expand access to thrombectomy in the U.S. and globally using the Remedy Robotics N1 system, a remotely operable endovascular robot that combines proprietary hardware and AI-enabled software.
- Remedy Robotics unveiled the N1 system earlier this month.
- The company touts N1 as the world’s first remotely operable endovascular robot.
- This marks the second partnership for the company in recent weeks after a deal with the Australian Stroke Alliance.
Remedy Robotics combines proprietary hardware and AI-enabled software to enable faster, safer and more effective innovation in cardiovascular conditions.
Author’s summary: Remedy Robotics partners with Mission Thrombectomy to expand robotic thrombectomy access globally.
More News
- China Bistro Ignites Ealing with Tangra Spice and 50% Off Food
- Appellation Healdsburg - a flagship culinary hotel rooted in craft and community • Hotel Designs
- Andy Cohen Praises a Dallas Church for its Reponse to Gov. Abbott's War on Crosswalks
- Chicago-area Transit crisis: 7 principles to guide Illinois transportation reform
- Man hospitalized after South Miami-Dade home catches fire overnight - WSVN 7News | Miami News, Weather, Sports | Fort Lauderdale
- How is Financial Compensation Determined in a Car Accident?
- Hugo Rodrigues: A nine-member Cornwall city council? That's disappointing
- e.l.f.'s 2025 Impact Report Highlights Some Seriously Major Wins
- Thousand Oaks Biologics Showcases Integrated ADC CRDMO Solutions & Media Innovation for Industrialization at CPHI Frankfurt 2025
- Vietnam Draft AI Law: Regulatory Milestone and Business Implications